Literature DB >> 12604539

Active-site residues of Escherichia coli DNA gyrase required in coupling ATP hydrolysis to DNA supercoiling and amino acid substitutions leading to novobiocin resistance.

Christian H Gross1, Jonathan D Parsons, Trudy H Grossman, Paul S Charifson, Steven Bellon, James Jernee, Maureen Dwyer, Stephen P Chambers, William Markland, Martyn Botfield, Scott A Raybuck.   

Abstract

DNA gyrase is a bacterial type II topoisomerase which couples the free energy of ATP hydrolysis to the introduction of negative supercoils into DNA. Amino acids in proximity to bound nonhydrolyzable ATP analog (AMP. PNP) or novobiocin in the gyrase B (GyrB) subunit crystal structures were examined for their roles in enzyme function and novobiocin resistance by site-directed mutagenesis. Purified Escherichia coli GyrB mutant proteins were complexed with the gyrase A subunit to form the functional A(2)B(2) gyrase enzyme. Mutant proteins with alanine substitutions at residues E42, N46, E50, D73, R76, G77, and I78 had reduced or no detectable ATPase activity, indicating a role for these residues in ATP hydrolysis. Interestingly, GyrB proteins with P79A and K103A substitutions retained significant levels of ATPase activity yet demonstrated no DNA supercoiling activity, even with 40-fold more enzyme than the wild-type enzyme, suggesting that these amino acid side chains have a role in the coupling of the two activities. All enzymes relaxed supercoiled DNA to the same extent as the wild-type enzyme did, implying that only ATP-dependent reactions were affected. Mutant genes were examined in vivo for their abilities to complement a temperature-sensitive E. coli gyrB mutant, and the activities correlated well with the in vitro activities. We show that the known R136 novobiocin resistance mutations bestow a significant loss of inhibitor potency in the ATPase assay. Four new residues (D73, G77, I78, and T165) that, when changed to the appropriate amino acid, result in both significant levels of novobiocin resistance and maintain in vivo function were identified in E. coli.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12604539      PMCID: PMC149296          DOI: 10.1128/AAC.47.3.1037-1046.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  48 in total

1.  Mutation in the DNA gyrase A Gene of Escherichia coli that expands the quinolone resistance-determining region.

Authors:  S M Friedman; T Lu; K Drlica
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

2.  Timely release of both replication forks from oriC requires modulation of origin topology.

Authors:  N Smelkova; K J Marians
Journal:  J Biol Chem       Date:  2001-08-14       Impact factor: 5.157

3.  Hydrolysis of ATP at only one GyrB subunit is sufficient to promote supercoiling by DNA gyrase.

Authors:  S C Kampranis; A Maxwell
Journal:  J Biol Chem       Date:  1998-10-09       Impact factor: 5.157

4.  Isolation and characterisation of a strain carrying a conditional lethal mutation in the cou gene of Escherichia coli K12.

Authors:  E Orr; N F Fairweather; I B Holland; R H Pritchard
Journal:  Mol Gen Genet       Date:  1979

5.  DNA transport by a type II DNA topoisomerase: evidence in favor of a two-gate mechanism.

Authors:  J Roca; J C Wang
Journal:  Cell       Date:  1994-05-20       Impact factor: 41.582

Review 6.  Inactivation of antibiotics and the dissemination of resistance genes.

Authors:  J Davies
Journal:  Science       Date:  1994-04-15       Impact factor: 47.728

7.  Regulation of the genes for E. coli DNA gyrase: homeostatic control of DNA supercoiling.

Authors:  R Menzel; M Gellert
Journal:  Cell       Date:  1983-08       Impact factor: 41.582

8.  The interaction of coumarin antibiotics with fragments of DNA gyrase B protein.

Authors:  N A Gormley; G Orphanides; A Meyer; P M Cullis; A Maxwell
Journal:  Biochemistry       Date:  1996-04-16       Impact factor: 3.162

9.  An unusual mechanism for resistance to the antibiotic coumermycin A1.

Authors:  I del Castillo; J L Vizán; M C Rodríguez-Sáinz; F Moreno
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

10.  The interaction of the F plasmid killer protein, CcdB, with DNA gyrase: induction of DNA cleavage and blocking of transcription.

Authors:  S E Critchlow; M H O'Dea; A J Howells; M Couturier; M Gellert; A Maxwell
Journal:  J Mol Biol       Date:  1997-11-07       Impact factor: 5.469

View more
  24 in total

1.  DNA gyrase is involved in chloroplast nucleoid partitioning.

Authors:  Hye Sun Cho; Sang Sook Lee; Kwang Dong Kim; Inhwan Hwang; Jong-Seok Lim; Youn-Il Park; Hyun-Sook Pai
Journal:  Plant Cell       Date:  2004-09-14       Impact factor: 11.277

2.  Crystal structures of Escherichia coli topoisomerase IV ParE subunit (24 and 43 kilodaltons): a single residue dictates differences in novobiocin potency against topoisomerase IV and DNA gyrase.

Authors:  Steven Bellon; Jonathan D Parsons; Yunyi Wei; Koto Hayakawa; Lora L Swenson; Paul S Charifson; Judith A Lippke; Robert Aldape; Christian H Gross
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

3.  Dual targeting of GyrB and ParE by a novel aminobenzimidazole class of antibacterial compounds.

Authors:  Trudy H Grossman; Douglas J Bartels; Steve Mullin; Christian H Gross; Jonathan D Parsons; Yusheng Liao; Anne-Laure Grillot; Dean Stamos; Eric R Olson; Paul S Charifson; Nagraj Mani
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

Review 4.  In front of and behind the replication fork: bacterial type IIA topoisomerases.

Authors:  Claudia Sissi; Manlio Palumbo
Journal:  Cell Mol Life Sci       Date:  2010-02-18       Impact factor: 9.261

5.  Mycobacterial mistranslation is necessary and sufficient for rifampicin phenotypic resistance.

Authors:  Babak Javid; Flavia Sorrentino; Melody Toosky; Wen Zheng; Jessica T Pinkham; Nina Jain; Miaomiao Pan; Padraig Deighan; Eric J Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-06       Impact factor: 11.205

6.  In vitro characterization of the antibacterial spectrum of novel bacterial type II topoisomerase inhibitors of the aminobenzimidazole class.

Authors:  Nagraj Mani; Christian H Gross; Jonathan D Parsons; Brian Hanzelka; Ute Müh; Steve Mullin; Yusheng Liao; Anne-Laure Grillot; Dean Stamos; Paul S Charifson; Trudy H Grossman
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

7.  Real-time visualization of photochemically induced fluorescence of 8-halogenated quinolones: lomefloxacin, clinafloxacin and Bay3118 in live human HaCaT keratinocytes.

Authors:  Edmond B Koker; Piotr J Bilski; Ann G Motten; Baozhong Zhao; Colin F Chignell; Yu-Ying He
Journal:  Photochem Photobiol       Date:  2010-05-13       Impact factor: 3.421

8.  A high-throughput fluorescence polarization assay for inhibitors of gyrase B.

Authors:  Bryan T Glaser; Jeremiah P Malerich; Sarah J Duellman; Julie Fong; Christopher Hutson; Richard M Fine; Boris Keblansky; Mary J Tang; Peter B Madrid
Journal:  J Biomol Screen       Date:  2011-01-18

9.  Protective effect of Qnr on agents other than quinolones that target DNA gyrase.

Authors:  George A Jacoby; Marian A Corcoran; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2015-08-03       Impact factor: 5.191

10.  Functional interactions between gyrase subunits are optimized in a species-specific manner.

Authors:  Daniela Weidlich; Dagmar Klostermeier
Journal:  J Biol Chem       Date:  2020-01-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.